These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11535577)

  • 1. Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection.
    Glover DK; Ruiz M; Takehana K; Petruzella FD; Riou LM; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
    Circulation; 2001 Sep; 104(10):1181-7. PubMed ID: 11535577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist.
    Patel RA; Glover DK; Broisat A; Kabul HK; Ruiz M; Goodman NC; Kramer CM; Meerdink DJ; Linden J; Beller GA
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H637-42. PubMed ID: 19502555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
    Okusa MD; Linden J; Huang L; Rosin DL; Smith DF; Sullivan G
    Kidney Int; 2001 Jun; 59(6):2114-25. PubMed ID: 11380813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia.
    Glover DK; Ruiz M; Takehana K; Petruzella FD; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3164-71. PubMed ID: 17308004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation.
    Riou LM; Ruiz M; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA; Glover DK
    J Am Coll Cardiol; 2002 Nov; 40(9):1687-94. PubMed ID: 12427424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism.
    Reece TB; Kron IL; Okonkwo DO; Laurent JJ; Tache-Leon C; Maxey TS; Ellman PI; Linden J; Tribble CG; Kern JA
    J Vasc Surg; 2006 Aug; 44(2):392-7. PubMed ID: 16890874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist.
    Glover DK; Ruiz M; Yang JY; Koplan BA; Allen TR; Smith WH; Watson DD; Barrett RJ; Beller GA
    Circulation; 1996 Oct; 94(7):1726-32. PubMed ID: 8840867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial blood flow and myocardial uptake of (201)Tl and (99m)Tc-sestamibi during coronary vasodilation induced by CGS-21680, a selective adenosine A(2A) receptor agonist.
    He ZX; Cwajg E; Hwang W; Hartley CJ; Funk E; Michael LH; Verani MS
    Circulation; 2000 Jul; 102(4):438-44. PubMed ID: 10908217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation.
    Peirce SM; Skalak TC; Rieger JM; Macdonald TL; Linden J
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H67-74. PubMed ID: 11406470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion.
    Cassada DC; Tribble CG; Laubach VE; Nguyen BN; Rieger JM; Linden J; Kaza AK; Long SM; Kron IL; Kern JA
    J Vasc Surg; 2001 Sep; 34(3):482-8. PubMed ID: 11533601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion.
    Fiser SM; Tribble CG; Kaza AK; Long SM; Kern JA; Cassada DC; Linden J; Rieger J; Laubach VE; Matisoff A; Kron IL
    J Thorac Cardiovasc Surg; 2002 Nov; 124(5):973-8. PubMed ID: 12407381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma.
    Reece TB; Davis JD; Okonkwo DO; Maxey TS; Ellman PI; Li X; Linden J; Tribble CG; Kron IL; Kern JA
    J Surg Res; 2004 Sep; 121(1):130-4. PubMed ID: 15313386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
    Glover DK; Riou LM; Ruiz M; Sullivan GW; Linden J; Rieger JM; Macdonald TL; Watson DD; Beller GA
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1851-8. PubMed ID: 15591104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion.
    Cassada DC; Tribble CG; Kaza AK; Fiser SM; Long SM; Linden J; Rieger JM; Kron IL; Kern JA
    Surgery; 2001 Aug; 130(2):230-5. PubMed ID: 11490354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons.
    Cassada DC; Tribble CG; Long SM; Kaza AK; Linden J; Rieger JM; Rosin D; Kron IL; Kern JA
    Ann Thorac Surg; 2002 Sep; 74(3):846-9; discussion 849-50. PubMed ID: 12238849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective adenosine A receptor agonist, ATL-146e, attenuates stress-induced gastric lesions in rats.
    Odashima M; Otaka M; Jin M; Komatsu K; Wada I; Matsuhashi T; Horikawa Y; Hatakeyama N; Oyake J; Ohba R; Linden J; Watanabe S
    J Gastroenterol Hepatol; 2005 Feb; 20(2):275-80. PubMed ID: 15683432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adenosine 2A receptor agonist ATL-146e attenuates experimental posthemorrhagic vasospasm.
    Chang CZ; Dumont AS; Simsek S; Titus BJ; Kwan AL; Kassell NF; Solenski NJ
    Neurosurgery; 2007 Jun; 60(6):1110-7; discussion 1117-8. PubMed ID: 17538386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of increased lipid concentration and hyperemic blood flow on the intrinsic myocardial washout kinetics of (99m)TcN-NOET.
    Riou LM; Unger S; Toufektsian MC; Ruiz M; Watson DD; Beller GA; Glover DK
    J Nucl Med; 2003 Jul; 44(7):1092-8. PubMed ID: 12843227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice.
    Odashima M; Otaka M; Jin M; Horikawa Y; Matsuhashi T; Ohba R; Linden J; Watanabe S
    Biochem Biophys Res Commun; 2006 Sep; 347(4):949-54. PubMed ID: 16859640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.